361 related articles for article (PubMed ID: 21615170)
1. Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles.
Ashley CE; Carnes EC; Phillips GK; Durfee PN; Buley MD; Lino CA; Padilla DP; Phillips B; Carter MB; Willman CL; Brinker CJ; Caldeira Jdo C; Chackerian B; Wharton W; Peabody DS
ACS Nano; 2011 Jul; 5(7):5729-45. PubMed ID: 21615170
[TBL] [Abstract][Full Text] [Related]
2. Immunogenic display of diverse peptides on virus-like particles of RNA phage MS2.
Peabody DS; Manifold-Wheeler B; Medford A; Jordan SK; do Carmo Caldeira J; Chackerian B
J Mol Biol; 2008 Jun; 380(1):252-63. PubMed ID: 18508079
[TBL] [Abstract][Full Text] [Related]
3. MS2 viruslike particles: a robust, semisynthetic targeted drug delivery platform.
Galaway FA; Stockley PG
Mol Pharm; 2013 Jan; 10(1):59-68. PubMed ID: 23110441
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution of Antibody-MS2 Viral Capsid Conjugates in Breast Cancer Models.
Aanei IL; ElSohly AM; Farkas ME; Netirojjanakul C; Regan M; Taylor Murphy S; O'Neil JP; Seo Y; Francis MB
Mol Pharm; 2016 Nov; 13(11):3764-3772. PubMed ID: 27611245
[TBL] [Abstract][Full Text] [Related]
5. MS2 Virus-like Particles as a Versatile Peptide Presentation Platform: Insights into the Deterministic Abilities for Accommodating Heterologous Peptide Lengths.
Dang M; Wu LJ; Zhang SR; Zhu JR; Hu YZ; Yang CX; Zhang XY
ACS Synth Biol; 2023 Dec; 12(12):3704-3715. PubMed ID: 37946498
[TBL] [Abstract][Full Text] [Related]
6. VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirus.
Tumban E; Peabody J; Tyler M; Peabody DS; Chackerian B
PLoS One; 2012; 7(11):e49751. PubMed ID: 23185426
[TBL] [Abstract][Full Text] [Related]
7. Armored long non-coding RNA MEG3 targeting EGFR based on recombinant MS2 bacteriophage virus-like particles against hepatocellular carcinoma.
Chang L; Wang G; Jia T; Zhang L; Li Y; Han Y; Zhang K; Lin G; Zhang R; Li J; Wang L
Oncotarget; 2016 Apr; 7(17):23988-4004. PubMed ID: 26992211
[TBL] [Abstract][Full Text] [Related]
8. Display of single-chain variable fragments on bacteriophage MS2 virus-like particles.
Lino CA; Caldeira JC; Peabody DS
J Nanobiotechnology; 2017 Feb; 15(1):13. PubMed ID: 28193211
[TBL] [Abstract][Full Text] [Related]
9. Dual Surface Modification of Genome-Free MS2 Capsids for Delivery Applications.
Aanei IL; Francis MB
Methods Mol Biol; 2018; 1776():629-642. PubMed ID: 29869270
[TBL] [Abstract][Full Text] [Related]
10. A novel delivery platform based on Bacteriophage MS2 virus-like particles.
Fu Y; Li J
Virus Res; 2016 Jan; 211():9-16. PubMed ID: 26415756
[TBL] [Abstract][Full Text] [Related]
11. Development of an antisense RNA delivery system using conjugates of the MS2 bacteriophage capsids and HIV-1 TAT cell-penetrating peptide.
Wei B; Wei Y; Zhang K; Wang J; Xu R; Zhan S; Lin G; Wang W; Liu M; Wang L; Zhang R; Li J
Biomed Pharmacother; 2009 May; 63(4):313-8. PubMed ID: 18823738
[TBL] [Abstract][Full Text] [Related]
12. Novel miR-122 delivery system based on MS2 virus like particle surface displaying cell-penetrating peptide TAT for hepatocellular carcinoma.
Wang G; Jia T; Xu X; Chang L; Zhang R; Fu Y; Li Y; Yang X; Zhang K; Lin G; Han Y; Li J
Oncotarget; 2016 Sep; 7(37):59402-59416. PubMed ID: 27449085
[TBL] [Abstract][Full Text] [Related]
13. Cell-specific delivery of bacteriophage-encapsidated ricin A chain.
Wu M; Brown WL; Stockley PG
Bioconjug Chem; 1995; 6(5):587-95. PubMed ID: 8974458
[TBL] [Abstract][Full Text] [Related]
14. Impact of internal RNA on aggregation and electrokinetics of viruses: comparison between MS2 phage and corresponding virus-like particles.
Dika C; Duval JF; Ly-Chatain HM; Merlin C; Gantzer C
Appl Environ Microbiol; 2011 Jul; 77(14):4939-48. PubMed ID: 21622784
[TBL] [Abstract][Full Text] [Related]
15. Thermal stability of RNA phage virus-like particles displaying foreign peptides.
Caldeira JC; Peabody DS
J Nanobiotechnology; 2011 May; 9():22. PubMed ID: 21609437
[TBL] [Abstract][Full Text] [Related]
16. Development of a microRNA delivery system based on bacteriophage MS2 virus-like particles.
Pan Y; Zhang Y; Jia T; Zhang K; Li J; Wang L
FEBS J; 2012 Apr; 279(7):1198-208. PubMed ID: 22309233
[TBL] [Abstract][Full Text] [Related]
17. Optimizing the synthesis and purification of MS2 virus like particles.
Hashemi K; Ghahramani Seno MM; Ahmadian MR; Malaekeh-Nikouei B; Bassami MR; Dehghani H; Afkhami-Goli A
Sci Rep; 2021 Oct; 11(1):19851. PubMed ID: 34615923
[TBL] [Abstract][Full Text] [Related]
18. RNA bacteriophage capsid-mediated drug delivery and epitope presentation.
Brown WL; Mastico RA; Wu M; Heal KG; Adams CJ; Murray JB; Simpson JC; Lord JM; Taylor-Robinson AW; Stockley PG
Intervirology; 2002; 45(4-6):371-80. PubMed ID: 12602361
[TBL] [Abstract][Full Text] [Related]
19. Peptide epitope identification by affinity selection on bacteriophage MS2 virus-like particles.
Chackerian B; Caldeira Jdo C; Peabody J; Peabody DS
J Mol Biol; 2011 Jun; 409(2):225-37. PubMed ID: 21501621
[TBL] [Abstract][Full Text] [Related]
20. The application of virus-like particles as vaccines and biological vehicles.
Yan D; Wei YQ; Guo HC; Sun SQ
Appl Microbiol Biotechnol; 2015 Dec; 99(24):10415-32. PubMed ID: 26454868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
